Since loss of PVT1 RNA in colon cancer cell line reduces MYC protein to more normal levels [4], inhibiting PVT1 could be a more accessible and feasible therapeutic strategy for renal cancer. This evidence concerns the gene MYC and malignant colon neoplasm.